ATE45958T1 - Peptide, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung. - Google Patents

Peptide, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung.

Info

Publication number
ATE45958T1
ATE45958T1 AT86101515T AT86101515T ATE45958T1 AT E45958 T1 ATE45958 T1 AT E45958T1 AT 86101515 T AT86101515 T AT 86101515T AT 86101515 T AT86101515 T AT 86101515T AT E45958 T1 ATE45958 T1 AT E45958T1
Authority
AT
Austria
Prior art keywords
peptides
processes
preparation
compositions containing
pharmaceutically acceptable
Prior art date
Application number
AT86101515T
Other languages
English (en)
Inventor
Hiroshi Sugano
Ryuichi Ishida
Michio Yamamura
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of ATE45958T1 publication Critical patent/ATE45958T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT86101515T 1985-02-20 1986-02-06 Peptide, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung. ATE45958T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB08504357A GB2171101A (en) 1985-02-20 1985-02-20 Peptide and processes for preparation of the same
EP86101515A EP0194443B1 (de) 1985-02-20 1986-02-06 Peptide, diese enthaltende Zusammensetzungen und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE45958T1 true ATE45958T1 (de) 1989-09-15

Family

ID=10574792

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86101515T ATE45958T1 (de) 1985-02-20 1986-02-06 Peptide, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung.

Country Status (9)

Country Link
US (1) US4711878A (de)
EP (1) EP0194443B1 (de)
JP (1) JPS61191695A (de)
AT (1) ATE45958T1 (de)
CA (1) CA1265898A (de)
DE (1) DE3665309D1 (de)
ES (2) ES8705464A1 (de)
GB (1) GB2171101A (de)
HK (1) HK1591A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75641A (en) * 1984-07-10 1990-11-05 Tanabe Seiyaku Co 1-methyl-4,5-dihydro-orotyl-histidyl-prolinamide,its preparation and pharmaceutical compositions comprising it
US5686420A (en) * 1987-06-05 1997-11-11 Georgetown University Thyrotropin-releasing hormone analogs and method of use
JPS63316724A (ja) * 1987-06-19 1988-12-26 Nippon Shinyaku Co Ltd 抗けいれん剤
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL183764C (nl) * 1974-10-16 1989-01-16 Gruenenthal Gmbh Werkwijze voor de bereiding van een geneesmiddel met psychotrope of neurotrope werking en werkwijze voor de bereiding van een histidylprolineamide-derivaat.
JPS51118841A (en) * 1975-04-03 1976-10-19 Takeda Chem Ind Ltd A drug for improving and treating clouding of consciousness
JPS5944308B2 (ja) * 1976-03-23 1984-10-29 武田薬品工業株式会社 ペプタイド

Also Published As

Publication number Publication date
CA1265898A (en) 1990-02-13
HK1591A (en) 1991-01-11
ES557149A0 (es) 1988-02-16
JPH0564960B2 (de) 1993-09-16
GB8504357D0 (en) 1985-03-20
EP0194443B1 (de) 1989-08-30
US4711878A (en) 1987-12-08
DE3665309D1 (en) 1989-10-05
ES552193A0 (es) 1987-05-01
JPS61191695A (ja) 1986-08-26
GB2171101A (en) 1986-08-20
ES8705464A1 (es) 1987-05-01
EP0194443A3 (en) 1987-09-23
ES8801673A1 (es) 1988-02-16
EP0194443A2 (de) 1986-09-17

Similar Documents

Publication Publication Date Title
IL88507A (en) 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
EG18408A (en) Process for preparing novel substituted quinoline derivatives
HUT47217A (en) Process for producing pharmaceutical compositions containing indol derivatives as active components
UA19171A (uk) Спосіб одержаhhя фіhілалкіламіhів або їх фармакологічhо прийhятhих солей
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
GR3023934T3 (en) New naphthalene amides and sulfonamides, process for their preparation and pharmaceutical compositions containing them
ES8601915A1 (es) Un procedimiento para preparar derivados de piridazinona
ATE45958T1 (de) Peptide, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung.
ATE72447T1 (de) Chartreusinderivate und salze, diese enthaltende antitumorzusammensetzungen und verfahren zu ihrer herstellung.
ES8701189A1 (es) Procedimiento para preparar derivados s(carbamoil-fenilsele-nicos) de mercaptanos
EP0134582A3 (de) Peptide, Verfahren zur deren Herstellung und pharmazeutische Zusammensetzungen
ES2016305B3 (es) Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso.
ES8800140A1 (es) Un procedimiento para preparar un compuesto de n-fenil-trans-4-guanidincometilciclohexanocarboxamida.
MY101747A (en) Dihydroorotic acids derivative, processes for preparing the same
ZA845931B (en) 1-(4'-alkylsulphonylphenyl)-2-amino-1,3-propanediol n-substituted derivatives
ES8308833A1 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
HUP9800964A2 (hu) O- és S-tartalmú 6 tagú benzo-kondenzált heterociklusos vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES2065855A1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
GR860045B (en) Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient
GB8608893D0 (en) D-nor-7-ergoline derivatives
SE8305362D0 (sv) Novel substituted phenylazacycloalkanes, processes for preparation and pharmaceutical preparations for such compounds
ES8707529A1 (es) Procedimiento para preparar compuestos de imidazo-isoquinoleina y de imidazo-tienopiridina
ATE97902T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
EP0207514A3 (en) 1,4-dihydropyridine derivatives, process for preparing them, pharmaceutical composition and use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee